Generics - North America, Sun Pharmaceutical Industries

Filter

Popular Filters

Pfizer in $2.15 billion settlement from Teva and Sun for infringement of Protonix patent

12-06-2013

Global pharma behemoth Pfizer (NYSE: PFE) today (June 12) said it has reached a $2.15 billion settlement…

Gastro-intestinalsGenericsLegalNorth AmericaPatentsPfizerPharmaceuticalProtonixSun Pharmaceutical IndustriesTeva Pharmaceutical Industries

FDA approval of generic cancer drug Doxil is expected to help resolve shortage

06-02-2013

The US Food and Drug Administration has approved the first generic version of the cancer drug Doxil (doxorubicin…

DoxilGenericsJohnson & JohnsonLipodoxNorth AmericaOncologyRegulationSun Pharmaceutical Industries

Takeda sells non-Colcrys URL Pharma generic business to Sun Pharma; Eisai divests Gliadel Wafer in USA

17-12-2012

Japan's largest drugmaker, Takeda Pharmaceutical (TYO: 4502), has entered into a definitive agreement…

Arbor PharmaceuticalsColcrysEisaiGenericsGliadelMergers & AcquisitionsNorth AmericaOncologyPharmaceuticalSun Pharmaceutical IndustriesTakeda PharmaceuticalsURL Pharma

US Supreme Court ruling in Novo Nordisk Prandin case favors generic drugmakers

18-04-2012

The US Supreme Court yesterday reversed the US Court of Appeals for the Federal Circuit's April 2010…

Caraco PharmaceuticalDiabetesGenericsLegalNorth AmericaNovo NordiskPatentsPharmaceuticalPrandiMetPrandinrepaglinideSun Pharmaceutical Industries

Indian, Israeli and US drugmakers leap into US market with generic Seroquel

29-03-2012

Less than a week after a US District Court for the District of Columbia issued an opinion and order in…

AstraZenecaDr Reddy's LaboratoriesGenericsLupinMarkets & MarketingMylan LaboratoriesNeurologicalNorth AmericaQuetiapine FumarateSeroquelSun Pharmaceutical IndustriesTeva Pharmaceutical Industries

US FDA acts on cancer drugs shortages; move applauded by GPhA

22-02-2012

The US Food and Drug Administration this week spelt out a series of steps to increase the supply of critically…

APP PharmaceuticalsDoxilGenericsHospiraMarkets & MarketingmethotrexateNorth AmericaOncologyPharmaceuticalRegulationSun Pharmaceutical Industries

Back to top